Savara Inc
NASDAQ:SVRA

Watchlist Manager
Savara Inc Logo
Savara Inc
NASDAQ:SVRA
Watchlist
Price: 2.78 USD 2.96% Market Closed
Market Cap: 477.1m USD

EV/EBITDA
Enterprise Value to EBITDA

-3.2
Current
-4.7
Median
4
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-3.2
=
Enterprise Value
282.1m USD
/
EBITDA
-89.5m USD
Market Cap EV/EBITDA
US
Savara Inc
NASDAQ:SVRA
474.9m USD -3.2
FR
Pharnext SCA
OTC:PNEXF
6T USD -212 079.3
US
Abbvie Inc
NYSE:ABBV
362.4B USD 16.7
US
Amgen Inc
NASDAQ:AMGN
165B USD 16.3
US
Gilead Sciences Inc
NASDAQ:GILD
139.9B USD 11.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.1B USD 26.1
US
Epizyme Inc
F:EPE
94.1B EUR -532.7
AU
CSL Ltd
ASX:CSL
122.4B AUD 17.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
70.2B USD 10.3
US
Seagen Inc
F:SGT
39.3B EUR -60.9
NL
argenx SE
XBRU:ARGX
33B EUR 315.4
EBITDA Growth EV/EBITDA to Growth
US
Savara Inc
NASDAQ:SVRA
Average EV/EBITDA: 59.1
Negative Multiple: -3.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -212 079.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
13%
1.3
US
Amgen Inc
NASDAQ:AMGN
16.3
17%
1
US
Gilead Sciences Inc
NASDAQ:GILD
11.4
7%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.1
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.7 N/A N/A
AU
CSL Ltd
ASX:CSL
17.3
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
10.3
14%
0.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.9 N/A N/A
NL
argenx SE
XBRU:ARGX
315.4
166%
1.9

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-5.7
2-Years Forward
EV/EBITDA
-7.2
3-Years Forward
EV/EBITDA
47.7